RxDoctor Payments Data

Todd Boren, MD

Gynecology · Chattanooga, TNNPI 1730142340

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,479 of the $5,210 with a category attached, or 86.0%. It is spread thinly across 33 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Among gynecology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,210in general payments, 2019–2025

Across 198 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Astellas Pharma US Inc$677
  • Merck$550
  • GSK$458
  • Eisai Inc.$393
  • Daiichi Sankyo Inc.$332
  • plus $2K from 27 others

What the payments were for

  • Consulting fees$3336%
  • Food & beverage$4,47986%
  • Education$3978%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,210 in reported general payments places this provider in the 90th percentile of 57 gynecology providers in Tennessee.

See all gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$118,605
Medicare patients
230
Services billed
640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated19$6,609
Estradiol41$2,443
Ondansetron Hcl18$2,008
Letrozole27$596
Clobetasol Propionate23$550
Prochlorperazine Maleate82$517
Ketorolac Tromethamine24$392
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$237
Fluconazole23$78
Oxycodone Hcl15$73
Ciprofloxacin Hcl14$66

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$59$6,60919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 57 gynecology providers in Tennessee.

Other gynecology in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →